Vaxcyte (PCVX) Earnings Date & Reports

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PCVX is expected to report earnings to rise 3.92% to -105 cents per share on May 12

Q1'25

Est.

$-1.06

Q4'24

Beat

by $0.10

Q3'24

Beat

by $0.27

Q2'24

Missed

by $0.12

Q1'24

Beat

by $0.28

The last earnings report on February 25 showed earnings per share of -101 cents, beating the estimate of -112 cents. With 8.89M shares outstanding, the current market capitalization sits at 4.15B.

View a ticker or compare two or three

Compare

PCVX